|
1
|
Sherman SI: Thyroid carcinoma. Lancet.
361:501–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hundahl SA, Fleming ID, Fremgen AM and
Menck HR: A National Cancer Data Base report on 53,856 cases of
thyroid carcinoma treated in the U.S., 1985–1995. Cancer.
83:2638–2648. 1998.PubMed/NCBI
|
|
3
|
Caron NR and Clark OH: Well differentiated
thyroid cancer. Scand J Surg. 93:261–271. 2004.PubMed/NCBI
|
|
4
|
Scheumann GF, Gimm O, Wegener G,
Hundeshagen H and Dralle H: Prognostic significance and surgical
management of locoregional lymph node metastases in papillary
thyroid cancer. World J Surg. 18:559–567. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang TS, Dubner S, Sznyter LA and Heller
KS: Incidence of metastatic well-differentiated thyroid cancer in
cervical lymph nodes. Arch Otolaryngol Head Neck Surg. 130:110–113.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chow SM, Law SC, Chan JK, Au SK, Yau S and
Lau WH: Papillary microcarcinoma of the thyroid: prognostic
significance of lymph node metastasis and multifocality. Cancer.
98:31–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qubain SW, Nakano S, Baba M, Takao S and
Aikou T: Distribution of lymph node micrometastasis in pN0
well-differentiated thyroid carcinoma. Surgery. 131:249–256. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arturi F, Russo D, Giuffrida D, et al:
Early diagnosis by genetic analysis of differentiated thyroid
cancer metastases in small lymph nodes. J Clin Endocrinol Metab.
82:1638–1641. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wada N, Duh QY, Sugino K, et al: Lymph
node metastasis from 259 papillary thyroid microcarcinomas:
frequency, pattern of occurrence and recurrence, and optimal
strategy for neck dissection. Ann Surg. 237:399–407. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shattuck TM, Westra WH, Ladenson PW and
Arnold A: Independent clonal origins of distinct tumor foci in
multifocal papillary thyroid carcinoma. N Engl J Med.
352:2406–2412. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morris LG and Myssiorek D: Improved
detection does not fully explain the rising incidence of
well-differentiated thyroid cancer: a population-based analysis. Am
J Surg. 200:454–461. 2010. View Article : Google Scholar
|
|
12
|
Giannini R, Ugolini C, Lupi C, et al: The
heterogeneous distribution of BRAF mutation supports the
independent clonal origin of distinct tumor foci in multifocal
papillary thyroid carcinoma. J Clin Endocrinol Metab. 92:3511–3516.
2007. View Article : Google Scholar
|
|
13
|
Park SY, Park YJ, Lee YJ, et al: Analysis
of differential BRAF(V600E) mutational status in multifocal
papillary thyroid carcinoma: evidence of independent clonal origin
in distinct tumor foci. Cancer. 107:1831–1838. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hay ID, Thompson GB, Grant CS, et al:
Papillary thyroid carcinoma managed at the Mayo Clinic during six
decades (1940–1999): temporal trends in initial therapy and
long-term outcome in 2444 consecutively treated patients. World J
Surg. 26:879–885. 2002.PubMed/NCBI
|
|
15
|
Salter KD, Andersen PE, Cohen JI, et al:
Central nodal metastases in papillary thyroid carcinoma based on
tumor histologic type and focality. Arch Otolaryngol Head Neck
Surg. 136:692–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mazeh H, Samet Y, Hochstein D, et al:
Multifocality in well-differentiated thyroid carcinomas calls for
total thyroidectomy. Am J Surg. 201:770–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shaha AR: Implications of prognostic
factors and risk groups in the management of differentiated thyroid
cancer. Laryngoscope. 114:393–402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katoh R, Sasaki J, Kurihara H, Suzuki K,
Iida Y and Kawaoi A: Multiple thyroid involvement (intraglandular
metastasis) in papillary thyroid carcinoma: a clinicopathologic
study of 105 consecutive patients. Cancer. 70:1585–1590. 1992.
View Article : Google Scholar
|
|
19
|
Tscholl-Ducommun J and Hedinger CE:
Papillary thyroid carcinomas: morphology and prognosis. Virchows
Arch A Pathol Anat Histol. 396:19–39. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hughes CJ, Shaha AR, Shah JP and Loree TR:
Impact of lymph node metastases in differentiated carcinoma of the
thyroid: a matched-pair analysis. Head Neck. 18:127–132. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
White ML, Gauger PG and Doherty GM:
Central lymph node dissection in differentiated thyroid cancer.
World J Surg. 31:895–904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shindo M, Wu JC, Park EE and Tanzella F:
The importance of central compartment elective lymph node excision
in the staging and treatment of papillary thyroid cancer. Arch
Otolaryngol Head Neck Surg. 132:650–654. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mazzaferri EL and Kloos RT: Clinical
review 128: Current approaches to primary therapy for papillary and
follicular thyroid cancer. J Clin Endocrinol Metab. 86:1447–1463.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xing M: BRAF mutation in thyroid cancer.
Endocr Relat Cancer. 12:245–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Riesco-Eizaguirre G, Gutiérrez-Martínez P,
García-Cabezas MA, Nistal M and Santisteban P: The oncogene BRAF
V600E is associated with a high risk of recurrence and less
differentiated papillary thyroid carcinoma due to the impairment of
Na+/I− targeting to the membrane. Endocr
Relat Cancer. 13:257–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, et
al: Analysis of differ ential BRAF(V600E) mutational status in high
aggressive papillary thyroid microcarcinoma. Ann Surg Oncol.
16:240–245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jovanovic L, Delahunt B, McIver B,
Eberhardt NL and Grebe SK: Most multifocal papillary thyroid
carcinomas acquire genetic and morphotype diversity through
subclonal evolution following the intra-glandular spread of the
initial neoplastic clone. J Pathol. 215:1451–1454. 2008. View Article : Google Scholar
|
